SAN FRANCISCO, April 17, 2018 -- Vascular access technology innovator Velano Vascular today announced that its PIVO™ needle-free device for blood draws was named the 2018 Gold Edison Award winner for innovation in patient care at last week’s 31st Annual Edison Awards Gala at The Capitale in New York City.
Inspired by Thomas Edison, the distinguished awards have recognized innovation, creativity and ingenuity in the global economy since 1987. Additional 2018 finalists in other categories include The Dow Chemical Company, Lenovo, NVIDIA, and GE Healthcare.
Velano Chief Executive Eric M. Stone said the company is excited to have taken home top honors at the Edison Awards. “Venous access and blood draws are a fundamental component of modern medicine, but traditionally rely on antiquated practices that are painful, inefficient, and put both patients and practitioners at risk,” explained Stone. “PIVO is the first in our family of technology solutions that leading hospitals are deploying with the aim of improving vascular access, reducing infection, and advancing a more humane and true standard of care for blood collection.”
More than one billion inpatient blood draws occur around the world every year, informing nearly 70% of all medical decisions. However, the rising incidence of aging, obesity and chronic illness is making venous access more difficult and less efficient. These patients, known as Difficult Venous Access (DVA), represent more than 30% of all hospitalized patients worldwide.
Velano’s pioneering technologies are ushering in a new standard of care for vascular access in hospitals. The company’s FDA-cleared PIVO device enables high quality blood draws from indwelling peripheral IV lines, and is currently in use at a number of health systems around the country.
The ballot of nominees for the Edison Awards™ was judged by a panel of more than 3,000 business executives including past award winners, academics and leaders in the fields of product development, design, engineering, science and medical.
About Edison Awards™
The Edison Awards is a program conducted by Edison Universe, a non-profit, 501(c)(3) organization dedicated to fostering future innovators. The Awards have been recognizing and honoring the best in innovations and innovators since 1987. They honor game-changing innovations that are at the forefront of new product and service development, marketing and human-centered design, and are one of the highest accolades a company can receive in the name of successful innovation. For more information about the Edison Awards complete program and a list of past winners, visit www.edisonawards.com.
About Velano Vascular
Velano Vascular is a medical device innovator committed to reducing the pain, risk and inefficiencies of traditional blood collection practices while enhancing the clinical domain of vascular access. The company’s revolutionary FDA-approved PIVO device expands the use of peripheral IV lines for frequent, high quality and needle free blood draws, aiming to deliver painless, compassionate care for hospital inpatients, a safer practice for caregivers, and a more financially responsible alternative for health systems. More information is available at www.velanovascular.com.
Press Contact:
Michael Azzano
Cosmo PR
[email protected]
415-596-1978


Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints
Same sparkle, different story: how lab-grown diamonds are transforming the market
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation
SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
Capital One Says AML Review Led to Closure of Trump Organization Accounts
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges 



